Increased miR-200a levels have been shown to modulate the Keap1/Nrf2 pathway, improving the fructose-related hepatitis and lipid deposition and affecting liver fibrosis development.13, 14 Unfortunately, there is very little research related to miR-200a in COPD. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.